Novel developments with selective, non-peptidic kappa-opioid receptor agonists

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.10, 1997-10, pp. : 1351-1368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-peptidic δ opioid receptor agonists and antagonists (2000 – 2012)

By Fujii Hideaki Takahashi Toshihiro Nagase Hiroshi

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 9, 2013-09 ,pp. : 1181-1208

Informa Healthcare

Access to resources Recommend Favorite

Kappa-opioid receptor ligands

By Husbands Stephen M

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 12, 2004-12 ,pp. : 1725-1741

Informa Healthcare

Access to resources Recommend Favorite

Antinociceptive effects of the selective non-peptidic -opioid receptor agonist TAN-67 in diabetic mice

By Kamei J. Saitoh A. Ohsawa M. Suzuki T. Misawa M. Nagase H. Kasuya Y.

European Journal of Pharmacology, Vol. 276, Iss. 1, 1995-03 ,pp. : 131-135

Elsevier

Access to resources Recommend Favorite

The Opioid Receptor Independent Actions of Kappa Receptor Agonists in the Cardiovascular System

Current Pharmaceutical Design, Vol. 10, Iss. 20, 2004-08 ,pp. : 2429-2444

Bentham Science Publishers

Access to resources Recommend Favorite

Non-peptidic urotensin-II receptor modulators

By Jin Jian Douglas Stephen A

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 467-479

Informa Healthcare

Access to resources Recommend Favorite